Xponance Inc. Decreases Position in Houlihan Lokey, Inc. (NYSE:HLI)

Xponance Inc. trimmed its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 9.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 5,937 shares of the financial services provider’s stock after selling 600 shares during the period. Xponance Inc.’s holdings in Houlihan Lokey were worth $801,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ameritas Investment Partners Inc. grew its position in Houlihan Lokey by 0.5% during the 1st quarter. Ameritas Investment Partners Inc. now owns 18,293 shares of the financial services provider’s stock worth $2,345,000 after acquiring an additional 97 shares during the last quarter. Park Avenue Securities LLC raised its holdings in Houlihan Lokey by 1.4% during the 2nd quarter. Park Avenue Securities LLC now owns 8,532 shares of the financial services provider’s stock valued at $1,151,000 after buying an additional 120 shares during the last quarter. Portside Wealth Group LLC raised its holdings in Houlihan Lokey by 6.3% during the 2nd quarter. Portside Wealth Group LLC now owns 2,224 shares of the financial services provider’s stock valued at $300,000 after buying an additional 131 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Houlihan Lokey by 27.7% in the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 746 shares of the financial services provider’s stock worth $100,000 after acquiring an additional 162 shares during the last quarter. Finally, Crewe Advisors LLC increased its position in shares of Houlihan Lokey by 264.5% in the second quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 164 shares during the period. 78.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total transaction of $30,498.00. Following the completion of the transaction, the director now directly owns 7,001 shares in the company, valued at $1,067,582.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Gillian Beth Zucker sold 200 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $152.49, for a total transaction of $30,498.00. Following the completion of the transaction, the director now directly owns 7,001 shares in the company, valued at $1,067,582.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 9,717 shares of company stock worth $1,479,513. 25.97% of the stock is currently owned by company insiders.

Houlihan Lokey Stock Down 0.4 %

HLI opened at $157.66 on Friday. Houlihan Lokey, Inc. has a 52 week low of $94.67 and a 52 week high of $162.84. The stock has a market cap of $10.81 billion, a PE ratio of 38.36 and a beta of 0.67. The business has a 50 day moving average of $152.02 and a 200-day moving average of $138.74.

Houlihan Lokey (NYSE:HLI) last announced its quarterly earnings data on Tuesday, July 30th. The financial services provider reported $1.22 EPS for the quarter, meeting the consensus estimate of $1.22. Houlihan Lokey had a return on equity of 18.80% and a net margin of 15.30%. The business had revenue of $514.00 million during the quarter, compared to analyst estimates of $508.70 million. During the same quarter last year, the firm posted $0.89 earnings per share. The company’s revenue for the quarter was up 23.6% on a year-over-year basis. Equities analysts anticipate that Houlihan Lokey, Inc. will post 5.54 EPS for the current year.

Houlihan Lokey Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Sunday, September 15th. Investors of record on Tuesday, September 3rd were paid a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend was Tuesday, September 3rd. Houlihan Lokey’s payout ratio is currently 55.47%.

Analyst Ratings Changes

A number of analysts have recently weighed in on HLI shares. UBS Group increased their target price on shares of Houlihan Lokey from $157.00 to $170.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $154.00 price objective (up from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. Wells Fargo & Company initiated coverage on Houlihan Lokey in a report on Thursday, September 12th. They set an “underweight” rating and a $149.00 target price for the company. Morgan Stanley lifted their price target on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a report on Monday, September 23rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $153.00.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.